FDA approves Extavia for multiple sclerosis
Extavia is designed to help MS patients manage their disease by reducing the frequency of episodes of neurological dysfunction that characterize the condition.
Extavia is designed to help MS patients manage their disease by reducing the frequency of episodes of neurological dysfunction that characterize the condition.
The FDA has detailed its guidelines for the use of so-called “investigational” drugs in the hopes that more people who might benefit from not-yet-approved medications can gain access to them.
H.R. 3200–the Obama administration’s hotly contested healthcare reform bill–is available in its entirety as a free download from the Library of Congress Web site.
Dr. Bernadine Healy gives four things that you and your representatives in Washington should know about the healthcare reform bill known as H.R. 3200.
Multiple sclerosis patient Elizabeth Kinder talks about how being one of 13 people accepted for a clinical trial of the new drug Fingolimod in the United Kingdom has given her new hope.
Optomotrists say that in addition to vision problems, a routine eye exam can help them detect such conditions as multiple sclerosis, diabetes, and high cholesterol.
The White House considers healthcare reform to be vital to a U.S. economic recovery and wants the legislation approved by the end of the year.
The House Energy and Commerce Committee has approved a sweeping bill designed to overhaul the U.S. healthcare system, clearing the way for a vote by the full House in the fall.